-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to Q1 2025.
- Atea Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$30.6M, a 23.3% increase year-over-year.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$135M, a 58.7% decline from 2023.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$85.4M, a 29.4% increase from 2022.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$121M, a 39.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)